| Pharmacology, physiology, and mechanisms of incretin hormone action JE Campbell, DJ Drucker Cell metabolism 17 (6), 819-837, 2013 | 1487 | 2013 |
| A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents B Finan, B Yang, N Ottaway, DL Smiley, T Ma, C Clemmensen, ... Nature medicine 21 (1), 27-36, 2015 | 606 | 2015 |
| Mechanisms controlling pancreatic islet cell function in insulin secretion JE Campbell, CB Newgard Nature reviews Molecular cell biology 22 (2), 142-158, 2021 | 403 | 2021 |
| GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic Male ApoE−/− Mice N Panjwani, EE Mulvihill, C Longuet, B Yusta, JE Campbell, TJ Brown, ... Endocrinology 154 (1), 127-139, 2013 | 367 | 2013 |
| Islet α cells and glucagon—critical regulators of energy homeostasis JE Campbell, DJ Drucker Nature reviews endocrinology 11 (6), 329-338, 2015 | 302 | 2015 |
| SIRT4 is a lysine deacylase that controls leucine metabolism and insulin secretion KA Anderson, FK Huynh, K Fisher-Wellman, JD Stuart, BS Peterson, ... Cell metabolism 25 (4), 838-855. e15, 2017 | 299 | 2017 |
| Adipogenic and lipolytic effects of chronic glucocorticoid exposure JE Campbell, AJ Peckett, AM D'souza, TJ Hawke, MC Riddell American Journal of Physiology-Cell Physiology 300 (1), C198-C209, 2011 | 287 | 2011 |
| Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist FS Willard, JD Douros, MBN Gabe, AD Showalter, DB Wainscott, ... JCI insight 5 (17), 2020 | 234 | 2020 |
| β Cell tone is defined by proglucagon peptides through cAMP signaling ME Capozzi, B Svendsen, SE Encisco, SL Lewandowski, MD Martin, ... JCI insight 4 (5), 2019 | 215 | 2019 |
| Effect of voluntary wheel running on circadian corticosterone release and on HPA axis responsiveness to restraint stress in Sprague-Dawley rats S Fediuc, JE Campbell, MC Riddell Journal of applied physiology 100 (6), 1867-1875, 2006 | 196 | 2006 |
| Revisiting the complexity of GLP-1 action from sites of synthesis to receptor activation BA McLean, CK Wong, JE Campbell, DJ Hodson, S Trapp, DJ Drucker Endocrine reviews 42 (2), 101-132, 2021 | 152 | 2021 |
| Glucagon lowers glycemia when β cells are active ME Capozzi, JB Wait, J Koech, AN Gordon, RW Coch, B Svendsen, ... JCI insight 4 (16), 2019 | 138 | 2019 |
| Inactivation of the cardiomyocyte glucagon-like peptide-1 receptor (GLP-1R) unmasks cardiomyocyte-independent GLP-1R-mediated cardioprotection JR Ussher, LL Baggio, JE Campbell, EE Mulvihill, M Kim, MG Kabir, ... Molecular metabolism 3 (5), 507-517, 2014 | 132 | 2014 |
| Targeting the incretin/glucagon system with triagonists to treat diabetes ME Capozzi, RD DiMarchi, MH Tschöp, B Finan, JE Campbell Endocrine reviews 39 (5), 719-738, 2018 | 129 | 2018 |
| Efficacy of continuous real-time blood glucose monitoring during and after prolonged high-intensity cycling exercise: spinning with a continuous glucose monitoring system KE Iscoe, JE Campbell, V Jamnik, BA Perkins, MC Riddell Diabetes technology & therapeutics 8 (6), 627-635, 2006 | 127 | 2006 |
| TCF1 links GIPR signaling to the control of beta cell function and survival JE Campbell, JR Ussher, EE Mulvihill, J Kolic, LL Baggio, X Cao, Y Liu, ... Nature medicine 22 (1), 84-90, 2016 | 125 | 2016 |
| A rodent model of rapid-onset diabetes induced by glucocorticoids and high-fat feeding Y Shpilberg, JL Beaudry, A D’Souza, JE Campbell, A Peckett, MC Riddell Disease models & mechanisms 5 (5), 671-680, 2012 | 120 | 2012 |
| Circulating levels of soluble dipeptidyl peptidase-4 are dissociated from inflammation and induced by enzymatic DPP4 inhibition EM Varin, EE Mulvihill, JL Beaudry, G Pujadas, S Fuchs, JF Tanti, S Fazio, ... Cell metabolism 29 (2), 320-334. e5, 2019 | 119 | 2019 |
| Pyruvate kinase controls signal strength in the insulin secretory pathway SL Lewandowski, RL Cardone, HR Foster, T Ho, E Potapenko, C Poudel, ... Cell metabolism 32 (5), 736-750. e5, 2020 | 109 | 2020 |
| Cellular sites and mechanisms linking reduction of dipeptidyl peptidase-4 activity to control of incretin hormone action and glucose homeostasis EE Mulvihill, EM Varin, B Gladanac, JE Campbell, JR Ussher, LL Baggio, ... Cell metabolism 25 (1), 152-165, 2017 | 100 | 2017 |
Daniel J. DruckerLunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital, University of Toronto在 lunenfeld.ca 的电子邮件经过验证
